Jack Cush

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, including Rheumatology success in the NRMP MATCH, Cocaine vasculitis and worrisome safety risks with Biologics and tsDMARDs.

Dr. Jack Cush discusses outdated terms in rheumatology, promoting more accurate terminology like 'CREST' and 'Churg Strauss'. He explores the evolution of fibromyalgia terminology, advocates for precise anatomical language, and delves into the historical context of Lumbago. Dr. Cush highlights the shift to scientifically accurate terms in rheumatology and the importance of precise terminology in medical communication.

Rheumatology specialists Drs. Cush, Yusof, and Fava discuss cutting-edge lupus therapies at EULAR 2024 conference. Topics include steroid reduction strategies, B-cell targeting meds, and promising results of ionolumab for cell depletion. They delve into Lupus treatment trials, advances in lupus nephritis therapies, biomarkers for disease activity prediction, and the dynamic nature of lupus nephritis.

Drs. Kavanaugh and Cush discuss topics from the EULAR 2024 Meeting, including the impact of anxiety on disease activity in RA patients, challenges in treating difficult cases of RA and psoriatic arthritis, recognizing and addressing depression symptoms, and exploring studies on ILD in RA patients. They also cover the use of AI in treatment analysis, CAR-T therapy for autoimmune diseases, and the efficacy of Dukravicitinib in managing lupus skin conditions.

Exploring topics such as infections in patients on biologics, H. pylori infection and GI complications, IL-17 inhibitors and lupus management, vaccinations in rheumatology, and the impact of depression on all-cause mortality in RA patients.

Explore the relationship between weather and musculoskeletal symptoms, the importance of strength in preventing falls and fractures, risks for joint issues in inflammatory bowel disease patients, innovations in biosimilars and monoclonal antibodies, and pregnancy outcomes in rheumatoid arthritis mothers

Exploring immunosuppression, prevalence, and its implications. Highlights include recent autoimmune disease research on inflammatory arthritis referrals, myositis diagnosis, lupus nephritis outcomes, infections in lupus patients, and advancements in treatment for autoimmune diseases like psoriasis and RA.

Dr. Jack Cush discusses the use of steroids in autoimmune diseases, disease activity in RA patients, telemedicine impact, fracture risk in CPPD disease, cancer risk in RA and AS patients, gout flare treatment with urea-lowering therapy, autoimmune disease prevention post VITAL trial, and skepticism towards vitamin D and omega-3 supplementation.

Dr. Jack Cush, a rheumatology expert, dives into the latest in medical news, including the recent approval of the Samsung Galaxy Watch for sleep apnea monitoring. He discusses polymyalgia rheumatica and innovative treatment approaches in rheumatology. Cush highlights new findings on inflammatory myopathies and the FDA’s approval of cecukinumab for arthritis. He also connects ACL injuries to accelerated osteoarthritis risks and reveals reproductive health concerns within scleroderma patients, showcasing significant health disparities.

Drs. Claire Owen, Anisha Dua, Stephen Paget, and Jack Cush discuss the diagnosis and monitoring of Polymyalgia Rheumatica (PMR), exploring topics such as using sedimentation rate as a diagnostic marker, the importance of biomarkers in diagnosis and monitoring, clinical presentation and response to treatment, challenges in diagnosing and monitoring PMR, the impact of serology on diagnosis, and the potential of advanced imaging techniques.